Investors Sue Abuse-Deterrent Opioid Co. After FDA Setback
Intellipharmaceutics International Inc. allegedly lied to its investors about how sure it was its abuse-deterrent opioid painkiller Rexista actually prevented abuse when applying for U.S. Food and Drug Administration approval, a...To view the full article, register now.
Already a subscriber? Click here to view full article